1 Influenza Virus Vaccine (H1N1) Market Overview 1.1 Influenza Virus Vaccine (H1N1) Product Overview 1.2 Influenza Virus Vaccine (H1N1) Market Segment by Type 1.2.1 Intramuscular Vaccine 1.2.2 Nasal Spray Vaccine 1.3 Global Influenza Virus Vaccine (H1N1) Market Size by Type 1.3.1 Global Influenza Virus Vaccine (H1N1) Market Size Overview by Type (2016-2027) 1.3.2 Global Influenza Virus Vaccine (H1N1) Historic Market Size Review by Type (2016-2021) 1.3.2.1 Global Influenza Virus Vaccine (H1N1) Sales Breakdown in Volume by Type (2016-2021) 1.3.2.2 Global Influenza Virus Vaccine (H1N1) Sales Breakdown in Value by Type (2016-2021) 1.3.2.3 Global Influenza Virus Vaccine (H1N1) Average Selling Price (ASP) by Type (2016-2021) 1.3.3 Global Influenza Virus Vaccine (H1N1) Forecasted Market Size by Type (2022-2027) 1.3.3.1 Global Influenza Virus Vaccine (H1N1) Sales Breakdown in Volume by Type (2022-2027) 1.3.3.2 Global Influenza Virus Vaccine (H1N1) Sales Breakdown in Value by Type (2022-2027) 1.3.3.3 Global Influenza Virus Vaccine (H1N1) Average Selling Price (ASP) by Type (2022-2027) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2016-2021) 1.4.2 Europe Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2016-2021) 1.4.3 Asia-Pacific Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2016-2021) 1.4.4 Latin America Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2016-2021) 1.4.5 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Breakdown by Type (2016-2021) 2 Global Influenza Virus Vaccine (H1N1) Market Competition by Company 2.1 Global Top Players by Influenza Virus Vaccine (H1N1) Sales (2016-2021) 2.2 Global Top Players by Influenza Virus Vaccine (H1N1) Revenue (2016-2021) 2.3 Global Top Players Influenza Virus Vaccine (H1N1) Price (2016-2021) 2.4 Global Top Manufacturers Influenza Virus Vaccine (H1N1) Manufacturing Base Distribution, Sales Area, Product Type 2.5 Influenza Virus Vaccine (H1N1) Market Competitive Situation and Trends 2.5.1 Influenza Virus Vaccine (H1N1) Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Influenza Virus Vaccine (H1N1) Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza Virus Vaccine (H1N1) as of 2020) 2.7 Date of Key Manufacturers Enter into Influenza Virus Vaccine (H1N1) Market 2.8 Key Manufacturers Influenza Virus Vaccine (H1N1) Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Influenza Virus Vaccine (H1N1) Status and Outlook by Region 3.1 Global Influenza Virus Vaccine (H1N1) Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Influenza Virus Vaccine (H1N1) Historic Market Size by Region 3.2.1 Global Influenza Virus Vaccine (H1N1) Sales in Volume by Region (2016-2021) 3.2.2 Global Influenza Virus Vaccine (H1N1) Sales in Value by Region (2016-2021) 3.2.3 Global Influenza Virus Vaccine (H1N1) Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Influenza Virus Vaccine (H1N1) Forecasted Market Size by Region 3.3.1 Global Influenza Virus Vaccine (H1N1) Sales in Volume by Region (2022-2027) 3.3.2 Global Influenza Virus Vaccine (H1N1) Sales in Value by Region (2022-2027) 3.3.3 Global Influenza Virus Vaccine (H1N1) Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Influenza Virus Vaccine (H1N1) by Application 4.1 Influenza Virus Vaccine (H1N1) Market Segment by Application 4.1.1 3 To 10 Years Old 4.1.2 10 To 18 Years Old 4.1.3 Above 18 Years Old 4.1.4 Other 4.2 Global Influenza Virus Vaccine (H1N1) Market Size by Application 4.2.1 Global Influenza Virus Vaccine (H1N1) Market Size Overview by Application (2016-2027) 4.2.2 Global Influenza Virus Vaccine (H1N1) Historic Market Size Review by Application (2016-2021) 4.2.2.1 Global Influenza Virus Vaccine (H1N1) Sales Breakdown in Volume, by Application (2016-2021) 4.2.2.2 Global Influenza Virus Vaccine (H1N1) Sales Breakdown in Value, by Application (2016-2021) 4.2.2.3 Global Influenza Virus Vaccine (H1N1) Average Selling Price (ASP) by Application (2016-2021) 4.2.3 Global Influenza Virus Vaccine (H1N1) Forecasted Market Size by Application (2022-2027) 4.2.3.1 Global Influenza Virus Vaccine (H1N1) Sales Breakdown in Volume, by Application (2022-2027) 4.2.3.2 Global Influenza Virus Vaccine (H1N1) Sales Breakdown in Value, by Application (2022-2027) 4.2.3.3 Global Influenza Virus Vaccine (H1N1) Average Selling Price (ASP) by Application (2022-2027) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Influenza Virus Vaccine (H1N1) Sales Breakdown by Application (2016-2021) 4.3.2 Europe Influenza Virus Vaccine (H1N1) Sales Breakdown by Application (2016-2021) 4.3.3 Asia-Pacific Influenza Virus Vaccine (H1N1) Sales Breakdown by Application (2016-2021) 4.3.4 Latin America Influenza Virus Vaccine (H1N1) Sales Breakdown by Application (2016-2021) 4.3.5 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Breakdown by Application (2016-2021) 5 North America Influenza Virus Vaccine (H1N1) by Country 5.1 North America Influenza Virus Vaccine (H1N1) Historic Market Size by Country 5.1.1 North America Influenza Virus Vaccine (H1N1) Sales in Volume by Country (2016-2021) 5.1.2 North America Influenza Virus Vaccine (H1N1) Sales in Value by Country (2016-2021) 5.2 North America Influenza Virus Vaccine (H1N1) Forecasted Market Size by Country 5.2.1 North America Influenza Virus Vaccine (H1N1) Sales in Volume by Country (2022-2027) 5.2.2 North America Influenza Virus Vaccine (H1N1) Sales in Value by Country (2022-2027) 6 Europe Influenza Virus Vaccine (H1N1) by Country 6.1 Europe Influenza Virus Vaccine (H1N1) Historic Market Size by Country 6.1.1 Europe Influenza Virus Vaccine (H1N1) Sales in Volume by Country (2016-2021) 6.1.2 Europe Influenza Virus Vaccine (H1N1) Sales in Value by Country (2016-2021) 6.2 Europe Influenza Virus Vaccine (H1N1) Forecasted Market Size by Country 6.2.1 Europe Influenza Virus Vaccine (H1N1) Sales in Volume by Country (2022-2027) 6.2.2 Europe Influenza Virus Vaccine (H1N1) Sales in Value by Country (2022-2027) 7 Asia-Pacific Influenza Virus Vaccine (H1N1) by Region 7.1 Asia-Pacific Influenza Virus Vaccine (H1N1) Historic Market Size by Region 7.1.1 Asia-Pacific Influenza Virus Vaccine (H1N1) Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Influenza Virus Vaccine (H1N1) Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Influenza Virus Vaccine (H1N1) Forecasted Market Size by Region 7.2.1 Asia-Pacific Influenza Virus Vaccine (H1N1) Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Influenza Virus Vaccine (H1N1) Sales in Value by Region (2022-2027) 8 Latin America Influenza Virus Vaccine (H1N1) by Country 8.1 Latin America Influenza Virus Vaccine (H1N1) Historic Market Size by Country 8.1.1 Latin America Influenza Virus Vaccine (H1N1) Sales in Volume by Country (2016-2021) 8.1.2 Latin America Influenza Virus Vaccine (H1N1) Sales in Value by Country (2016-2021) 8.2 Latin America Influenza Virus Vaccine (H1N1) Forecasted Market Size by Country 8.2.1 Latin America Influenza Virus Vaccine (H1N1) Sales in Volume by Country (2022-2027) 8.2.2 Latin America Influenza Virus Vaccine (H1N1) Sales in Value by Country (2022-2027) 9 Middle East and Africa Influenza Virus Vaccine (H1N1) by Country 9.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Historic Market Size by Country 9.1.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Forecasted Market Size by Country 9.2.1 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Influenza Virus Vaccine (H1N1) Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Influenza Virus Vaccine (H1N1) Business 10.1 CSL 10.1.1 CSL Corporation Information 10.1.2 CSL Introduction and Business Overview 10.1.3 CSL Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 10.1.4 CSL Influenza Virus Vaccine (H1N1) Products Offered 10.1.5 CSL Recent Development 10.2 NVS(Novartis) 10.2.1 NVS(Novartis) Corporation Information 10.2.2 NVS(Novartis) Introduction and Business Overview 10.2.3 NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 10.2.4 CSL Influenza Virus Vaccine (H1N1) Products Offered 10.2.5 NVS(Novartis) Recent Development 10.3 Sanofi Pasteur 10.3.1 Sanofi Pasteur Corporation Information 10.3.2 Sanofi Pasteur Introduction and Business Overview 10.3.3 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 10.3.4 Sanofi Pasteur Influenza Virus Vaccine (H1N1) Products Offered 10.3.5 Sanofi Pasteur Recent Development 10.4 Medimmune 10.4.1 Medimmune Corporation Information 10.4.2 Medimmune Introduction and Business Overview 10.4.3 Medimmune Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 10.4.4 Medimmune Influenza Virus Vaccine (H1N1) Products Offered 10.4.5 Medimmune Recent Development 10.5 GSK 10.5.1 GSK Corporation Information 10.5.2 GSK Introduction and Business Overview 10.5.3 GSK Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 10.5.4 GSK Influenza Virus Vaccine (H1N1) Products Offered 10.5.5 GSK Recent Development 10.6 Baxter 10.6.1 Baxter Corporation Information 10.6.2 Baxter Introduction and Business Overview 10.6.3 Baxter Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 10.6.4 Baxter Influenza Virus Vaccine (H1N1) Products Offered 10.6.5 Baxter Recent Development 10.7 Beijing Kexing Bio-Vaccine 10.7.1 Beijing Kexing Bio-Vaccine Corporation Information 10.7.2 Beijing Kexing Bio-Vaccine Introduction and Business Overview 10.7.3 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 10.7.4 Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Products Offered 10.7.5 Beijing Kexing Bio-Vaccine Recent Development 10.8 Hualan Bio-Vaccine 10.8.1 Hualan Bio-Vaccine Corporation Information 10.8.2 Hualan Bio-Vaccine Introduction and Business Overview 10.8.3 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 10.8.4 Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Products Offered 10.8.5 Hualan Bio-Vaccine Recent Development 10.9 Changchun Changsheng Bio-Technology 10.9.1 Changchun Changsheng Bio-Technology Corporation Information 10.9.2 Changchun Changsheng Bio-Technology Introduction and Business Overview 10.9.3 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 10.9.4 Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Products Offered 10.9.5 Changchun Changsheng Bio-Technology Recent Development 10.10 Beijing Tiantan Bio-Products 10.10.1 Company Basic Information, Manufacturing Base and Competitors 10.10.2 Influenza Virus Vaccine (H1N1) Product Category, Application and Specification 10.10.3 Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales, Revenue, Price and Gross Margin (2016-2021) 10.10.4 Main Business Overview 10.10.5 Beijing Tiantan Bio-Products Recent Development 10.11 Jiangsu Yanshen Bio-Technology 10.11.1 Jiangsu Yanshen Bio-Technology Corporation Information 10.11.2 Jiangsu Yanshen Bio-Technology Introduction and Business Overview 10.11.3 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 10.11.4 Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Products Offered 10.11.5 Jiangsu Yanshen Bio-Technology Recent Development 10.12 Zhejiang Tianyuan Bio-Pharmaceutical 10.12.1 Zhejiang Tianyuan Bio-Pharmaceutical Corporation Information 10.12.2 Zhejiang Tianyuan Bio-Pharmaceutical Introduction and Business Overview 10.12.3 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 10.12.4 Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Products Offered 10.12.5 Zhejiang Tianyuan Bio-Pharmaceutical Recent Development 10.13 Dalian Yalifeng Bio-Pharmaceutical 10.13.1 Dalian Yalifeng Bio-Pharmaceutical Corporation Information 10.13.2 Dalian Yalifeng Bio-Pharmaceutical Introduction and Business Overview 10.13.3 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 10.13.4 Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Products Offered 10.13.5 Dalian Yalifeng Bio-Pharmaceutical Recent Development 10.14 Sinopharm 10.14.1 Sinopharm Corporation Information 10.14.2 Sinopharm Introduction and Business Overview 10.14.3 Sinopharm Influenza Virus Vaccine (H1N1) Sales, Revenue and Gross Margin (2016-2021) 10.14.4 Sinopharm Influenza Virus Vaccine (H1N1) Products Offered 10.14.5 Sinopharm Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Influenza Virus Vaccine (H1N1) Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Influenza Virus Vaccine (H1N1) Industrial Chain Analysis 11.4 Influenza Virus Vaccine (H1N1) Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Influenza Virus Vaccine (H1N1) Distributors 12.3 Influenza Virus Vaccine (H1N1) Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of Intramuscular Vaccine Table 2. Major Company of Nasal Spray Vaccine Table 3. Global Influenza Virus Vaccine (H1N1) Sales by Type 2016 VS 2021 VS 2027 (US$ Million) Table 4. Global Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021) & (K Doses) Table 5. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Type (2016-2021) Table 6. Global Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021) & (US& Million) Table 7. Global Influenza Virus Vaccine (H1N1) Market Share in Value by Type (2016-2021) Table 8. Global Influenza Virus Vaccine (H1N1) Price by Type (2016-2021) & (US$/Dose) Table 9. Global Influenza Virus Vaccine (H1N1) Sales by Type (2022-2027) & (K Doses) Table 10. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Type (2022-2027) Table 11. Global Influenza Virus Vaccine (H1N1) Sales by Type (2022-2027) & (US$ Million) Table 12. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Type (2022-2027) Table 13. Global Influenza Virus Vaccine (H1N1) Price by Type (2022-2027) & (US$/Dose) Table 14. North America Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021) & (K Doses) Table 15. North America Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021) & (US$ Million) Table 16. Europe Influenza Virus Vaccine (H1N1) Sales (K Doses) by Type (2016-2021) Table 17. Europe Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021) & (US$ Million) Table 18. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales (K Doses) by Type (2016-2021) Table 19. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021) & (US$ Million) Table 20. Latin America Influenza Virus Vaccine (H1N1) Sales (K Doses) by Type (2016-2021) Table 21. Latin America Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021) & (US$ Million) Table 22. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales (K Doses) by Type (2016-2021) Table 23. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Type (2016-2021) & (US$ Million) Table 24. Global Influenza Virus Vaccine (H1N1) Sales by Company (2016-2021) & (K Doses) Table 25. Global Influenza Virus Vaccine (H1N1) Sales Share by Company (2016-2021) Table 26. Global Influenza Virus Vaccine (H1N1) Revenue by Company (2016-2021) & (US$ Million) Table 27. Global Influenza Virus Vaccine (H1N1) Revenue Share by Company (2016-2021) Table 28. Global Market Influenza Virus Vaccine (H1N1) Price by Company (2016-2021) & (US$/Dose) Table 29. Global Influenza Virus Vaccine (H1N1) Top Manufacturers Manufacturing Base Distribution and Sales Area Table 30. Global Influenza Virus Vaccine (H1N1) Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza Virus Vaccine (H1N1) as of 2020 Table 32. Date of Key Manufacturers Enter into Influenza Virus Vaccine (H1N1) Market Table 33. Key Manufacturers Influenza Virus Vaccine (H1N1) Product Type Table 34. Mergers & Acquisitions, Expansion Plans Table 35. Global Influenza Virus Vaccine (H1N1) Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 36. Global Influenza Virus Vaccine (H1N1) Sales by Region (2016-2021) & (K Doses) Table 37. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Region (2016-2021) Table 38. Global Influenza Virus Vaccine (H1N1) Sales by Region (2016-2021) & (US$ Million) Table 39. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Region (2016-2021) Table 40. Global Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021) Table 41. Global Influenza Virus Vaccine (H1N1) Sales by Region (2022-2027) & (K Doses) Table 42. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Region (2022-2027) Table 43. Global Influenza Virus Vaccine (H1N1) Sales by Region (2022-2027) & (US$ Million) Table 44. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Region (2022-2027) Table 45. Global Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2022-2027) Table 46. Global Influenza Virus Vaccine (H1N1) Sales by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 47. Global Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) & (K Doses) Table 48. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Application (2016-2021) Table 49. Global Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) & (US$ Million) Table 50. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Application (2016-2021) Table 51. Global Influenza Virus Vaccine (H1N1) Price by Application (2016-2021) & (US$/Dose) Table 52. Global Influenza Virus Vaccine (H1N1) Sales by Application (2022-2027) & (K Doses) Table 53. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Application (2022-2027) Table 54. Global Influenza Virus Vaccine (H1N1) Sales by Application (2022-2027) & (US$ Million) Table 55. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Application (2022-2027) Table 56. Global Influenza Virus Vaccine (H1N1) Price by Application (2022-2027) & (US$/Dose) Table 57. North America Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) (K Doses) Table 58. North America Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) & (US$ Million) Table 59. North America Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Application in 2020 Table 60. Europe Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) (K Doses) Table 61. Europe Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) & (US$ Million) Table 62. Europe Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Application in 2020 Table 63. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) (K Doses) Table 64. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) & (US$ Million) Table 65. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Application in 2020 Table 66. Latin America Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) (K Doses) Table 67. Latin America Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) & (US$ Million) Table 68. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Application in 2020 Table 69. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) (K Doses) Table 70. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Application (2016-2021) & (US$ Million) Table 71. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Application in 2020 Table 72. North America Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021) & (K Doses) Table 73. North America Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Country (2016-2021) Table 74. North America Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021) & (US$ Million) Table 75. North America Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Country (2016-2021) Table 76. North America Influenza Virus Vaccine (H1N1) Sales by Country (2022-2027) & (K Doses) Table 77. North America Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Country (2022-2027) Table 78. North America Influenza Virus Vaccine (H1N1) Sales by Country (2022-2027) & (US$ Million) Table 79. North America Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Country (2022-2027) Table 80. Europe Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021) & (K Doses) Table 81. Europe Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Country (2016-2021) Table 82. Europe Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021) & (US$ Million) Table 83. Europe Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Country (2016-2021) Table 84. Europe Influenza Virus Vaccine (H1N1) Sales by Country (2022-2027) & (K Doses) Table 85. Europe Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Country (2022-2027) Table 86. Europe Influenza Virus Vaccine (H1N1) Sales by Country (2022-2027) & (US$ Million) Table 87. Europe Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Country (2022-2027) Table 88. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2016-2021) & (K Doses) Table 89. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Region (2016-2021) Table 90. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2016-2021) & (US$ Million) Table 91. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Region (2016-2021) Table 92. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2022-2027) & (K Doses) Table 93. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Region (2022-2027) Table 94. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales by Region (2022-2027) & (US$ Million) Table 95. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Region (2022-2027) Table 96. Latin America Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021) & (K Doses) Table 97. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Country (2016-2021) Table 98. Latin America Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021) & (US$ Million) Table 99. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Country (2016-2021) Table 100. Latin America Influenza Virus Vaccine (H1N1) Sales by Country (2022-2027) & (K Doses) Table 101. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Country (2022-2027) Table 102. Latin America Influenza Virus Vaccine (H1N1) Sales by Country (2022-2027) & (US$ Million) Table 103. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Country (2022-2027) Table 104. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021) & (K Doses) Table 105. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Country (2016-2021) Table 106. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country (2016-2021) & (US$ Million) Table 107. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Country (2016-2021) Table 108. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country (2022-2027) & (K Doses) Table 109. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Country (2022-2027) Table 110. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales by Country (2022-2027) & (US$ Million) Table 111. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Country (2022-2027) Table 112. CSL Corporation Information Table 113. CSL Introduction and Business Overview Table 114. CSL Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021) Table 115. CSL Influenza Virus Vaccine (H1N1) Product Table 116. CSL Recent Development Table 117. NVS(Novartis) Corporation Information Table 118. NVS(Novartis) Introduction and Business Overview Table 119. NVS(Novartis) Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021) Table 120. NVS(Novartis) Influenza Virus Vaccine (H1N1) Product Table 121. NVS(Novartis) Recent Development Table 122. Sanofi Pasteur Corporation Information Table 123. Sanofi Pasteur Introduction and Business Overview Table 124. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021) Table 125. Sanofi Pasteur Influenza Virus Vaccine (H1N1) Product Table 126. Sanofi Pasteur Recent Development Table 127. Medimmune Corporation Information Table 128. Medimmune Introduction and Business Overview Table 129. Medimmune Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021) Table 130. Medimmune Influenza Virus Vaccine (H1N1) Product Table 131. Medimmune Recent Development Table 132. GSK Corporation Information Table 133. GSK Introduction and Business Overview Table 134. GSK Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021) Table 135. GSK Influenza Virus Vaccine (H1N1) Product Table 136. GSK Recent Development Table 137. Baxter Corporation Information Table 138. Baxter Introduction and Business Overview Table 139. Baxter Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021) Table 140. Baxter Influenza Virus Vaccine (H1N1) Product Table 141. Baxter Recent Development Table 142. Beijing Kexing Bio-Vaccine Corporation Information Table 143. Beijing Kexing Bio-Vaccine Introduction and Business Overview Table 144. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021) Table 145. Beijing Kexing Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Table 146. Beijing Kexing Bio-Vaccine Recent Development Table 147. Hualan Bio-Vaccine Corporation Information Table 148. Hualan Bio-Vaccine Introduction and Business Overview Table 149. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021) Table 150. Hualan Bio-Vaccine Influenza Virus Vaccine (H1N1) Product Table 151. Hualan Bio-Vaccine Recent Development Table 152. Changchun Changsheng Bio-Technology Corporation Information Table 153. Changchun Changsheng Bio-Technology Introduction and Business Overview Table 154. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021) Table 155. Changchun Changsheng Bio-Technology Influenza Virus Vaccine (H1N1) Product Table 156. Changchun Changsheng Bio-Technology Recent Development Table 157. Beijing Tiantan Bio-Products Corporation Information Table 158. Beijing Tiantan Bio-Products Introduction and Business Overview Table 159. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021) Table 160. Beijing Tiantan Bio-Products Influenza Virus Vaccine (H1N1) Product Table 161. Beijing Tiantan Bio-Products Recent Development Table 162. Jiangsu Yanshen Bio-Technology Corporation Information Table 163. Jiangsu Yanshen Bio-Technology Introduction and Business Overview Table 164. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021) Table 165. Jiangsu Yanshen Bio-Technology Influenza Virus Vaccine (H1N1) Product Table 166. Jiangsu Yanshen Bio-Technology Recent Development Table 167. Zhejiang Tianyuan Bio-Pharmaceutical Corporation Information Table 168. Zhejiang Tianyuan Bio-Pharmaceutical Introduction and Business Overview Table 169. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021) Table 170. Zhejiang Tianyuan Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Table 171. Zhejiang Tianyuan Bio-Pharmaceutical Recent Development Table 172. Dalian Yalifeng Bio-Pharmaceutical Corporation Information Table 173. Dalian Yalifeng Bio-Pharmaceutical Introduction and Business Overview Table 174. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021) Table 175. Dalian Yalifeng Bio-Pharmaceutical Influenza Virus Vaccine (H1N1) Product Table 176. Dalian Yalifeng Bio-Pharmaceutical Recent Development Table 177. Sinopharm Corporation Information Table 178. Sinopharm Introduction and Business Overview Table 179. Sinopharm Influenza Virus Vaccine (H1N1) Sales (K Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2016-2021) Table 180. Sinopharm Influenza Virus Vaccine (H1N1) Product Table 181. Sinopharm Recent Development Table 182. Key Raw Materials Lists Table 183. Raw Materials Key Suppliers Lists Table 184. Influenza Virus Vaccine (H1N1) Market Trends Table 185. Influenza Virus Vaccine (H1N1) Market Drivers Table 186. Influenza Virus Vaccine (H1N1) Market Challenges Table 187. Influenza Virus Vaccine (H1N1) Market Restraints Table 188. Influenza Virus Vaccine (H1N1) Distributors List Table 189. Influenza Virus Vaccine (H1N1) Downstream Customers Table 190. Research Programs/Design for This Report Table 191. Key Data Information from Secondary Sources Table 192. Key Data Information from Primary Sources List of Figures Figure 1. Influenza Virus Vaccine (H1N1) Product Picture Figure 2. Global Influenza Virus Vaccine (H1N1) Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Influenza Virus Vaccine (H1N1) Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Influenza Virus Vaccine (H1N1) Sales Status and Outlook (2016-2027) & (K Doses) Figure 5. Product Picture of Intramuscular Vaccine Figure 6. Global Intramuscular Vaccine Sales YoY Growth (2016-2021) & (K Doses) Figure 7. Product Picture of Nasal Spray Vaccine Figure 8. Global Nasal Spray Vaccine Sales YoY Growth (2016-2021) & (K Doses) Figure 9. Global Influenza Virus Vaccine (H1N1) Sales by Type (2016-2027) & (US$ Million) Figure 10. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Type (2016-2021) Figure 11. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Type (2016-2021) Figure 12. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Type (2022-2027) Figure 13. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Type (2022-2027) Figure 14. North America Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Type in 2020 Figure 15. North America Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Type in 2020 Figure 16. Europe Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Type in 2020 Figure 17. Europe Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Type in 2020 Figure 18. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Type in 2020 Figure 19. Asia-Pacific Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Type in 2020 Figure 20. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Type in 2020 Figure 21. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Type in 2020 Figure 22. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Type in 2020 Figure 23. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Type in 2020 Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Influenza Virus Vaccine (H1N1) Sales in 2020 Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Influenza Virus Vaccine (H1N1) Revenue in 2020 Figure 26. Influenza Virus Vaccine (H1N1) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 27. Product Picture of 3 To 10 Years Old Figure 28. Global 3 To 10 Years Old Sales YoY Growth (2016-2027) & (K Doses) Figure 29. Product Picture of 10 To 18 Years Old Figure 30. Global 10 To 18 Years Old Sales YoY Growth (2016-2027) & (K Doses) Figure 31. Product Picture of Above 18 Years Old Figure 32. Global Above 18 Years Old Sales YoY Growth (2016-2027) & (K Doses) Figure 33. Product Picture of Other Figure 34. Global Other Sales YoY Growth (2016-2027) & (K Doses) Figure 35. Global Influenza Virus Vaccine (H1N1) Sales by Application (2016-2027) & (US$ Million) Figure 36. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Application (2016-2021) Figure 37. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Application (2016-2021) Figure 38. Global Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Application (2022-2027) Figure 39. North America Influenza Virus Vaccine (H1N1) Sales Market Share in Volume by Application in 2020 Figure 40. Latin America Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Application in 2020 Figure 41. Middle East and Africa Influenza Virus Vaccine (H1N1) Sales Market Share in Value by Application in 2020 Figure 42. Key Raw Materials Price Figure 43. Influenza Virus Vaccine (H1N1) Manufacturing Cost Structure Figure 44. Influenza Virus Vaccine (H1N1) Industrial Chain Analysis Figure 45. Channels of Distribution Figure 46. Distributors Profiles Figure 47. Bottom-up and Top-down Approaches for This Report Figure 48. Data Triangulation Figure 49. Key Executives Interviewed

CSL NVS(Novartis) Sanofi Pasteur Medimmune GSK Baxter Beijing Kexing Bio-Vaccine Hualan Bio-Vaccine Changchun Changsheng Bio-Technology Beijing Tiantan Bio-Products Jiangsu Yanshen Bio-Technology Zhejiang Tianyuan Bio-Pharmaceutical Dalian Yalifeng Bio-Pharmaceutical Sinopharm